Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Cannaworx and its Principals twelve products for market launch in the coming year, including two novel products derived from the company's pain relief phytocannabinoid formulations. Acquisition of 5 leaf labs offers access to more than 50 sales members in 21 states.
Lead Product(s): Phytocannabinoid
Therapeutic Area: Neurology Product Name: Undisclosed
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Cannaworx
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition May 19, 2020